Adefovir dipivoxil-induced development of osteomalacia and Fanconi syndrome during the treatment of hepatitis B virus (HBV)-related cirrhosis

Adefovir dipivoxil-induced development of osteomalacia and Fanconi syndrome during the treatment of hepatitis B virus (HBV)-related cirrhosis

Adefovir dipivoxil is a nucleotide analog reverse transcriptase inhibitor used to treat adult patients affected by HBeAg-positive and HBeAg-negative chronic hepatitis B and with clinical evidence of lamivudine-resistant hepatitis B virus (HBV). Adefovir administered at a dosage of 10 mg/day is gener...

Full description

Bibliographic Details
Main Authors: Orietta Staltari, Benedetto Caroleo, Andzelika Michniewicz, Giovambattista De Sarro, Franco Perticone, Luca Gallelli
Format: Article
Language:English
Published: SEEd 2014-12-01
Series:Clinical Management Issues
Subjects:
Adefovir dipivoxil
Osteomalacia
Fanconi syndrome
HBV
Cirrhosis
Online Access:https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/969

Internet

https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/969

Similar Items